ImmPACT Bio

May your Thanksgiving be bountiful with reasons to be grateful. Happy Thanksgiving!

We’re honored to be recognized as one of the BioSpace - Best Places to Work in 2025! A huge thank you to our dedicated team whose hard work makes this possible. It’s your passion that builds the vibrant, supportive culture we’re so proud of. #BestPlacestoWork #ThankYouTeam

We’re honored to be recognized as one of the BioSpace - Best Places to Work in 2025! A huge thank you to our dedicated team whose hard work makes this possible. It’s your passion that builds the vibrant, supportive culture we’re so proud of. #BestPlacestoWork #ThankYouTeam

On this Veterans Day, we thank those who have served and sacrificed for our country. Your dedication, courage, and resilience inspire us. #VeteransDay #ThankYouVeterans #Gratitude

We’re thrilled to announce that we’re now part of Lyell Immunopharma! Partnering with such a visionary team, dedicated to pushing the boundaries of cell therapy, marks an exciting new chapter in our journey. Together, we’re committed to accelerating access to breakthrough therapies for patients who need them most. #celltherapy #CART https://lyell.com/

Thrilled to announce that Lyell Immunopharma entered into a definitive agreement to acquire ImmPACT Bio! The combination will bring together a world-class Team and a pipeline of next-generation CAR T-cell therapies. Our first clinical data readout from IMPT-314’s ongoing Phase 1/2 study will be presented at a major medical conference later this year. “I am incredibly proud of the ImmPACT team and all of their accomplishments in developing next-generation CAR T-cell therapies,” stated Sumant Ramachandra, M.D., Ph.D., Chief Executive Officer of ImmPACT. “This transaction validates our novel science and enhances the potential for this therapy to make a meaningful impact on patients' lives. I am confident that in Lyell, we have found a team that shares our passion for advancing novel science to benefit patients.” Thank you to our employees, leadership team, collaborators, scientific and clinical partners, Founders, investors, Board of Directors, and many more people for the support as we built ImmPACT Bio from its academic roots to a company with several open INDs, ongoing clinical programs and a robust pipeline of next-generation CAR T-cell therapies. Read more here: https://lnkd.in/gy2dT-ta #CARTCellTherapy #NextGenerationTherapies #Biotechnology #MakeAnImmPACT

Welcome to the ImmPACT Bio team, Jesus Salas! #welcometotheteam, #cartcelltherapy, #MakeAnImmPACT

We stand with the fighters, celebrate the survivors, and honor the memory of those we've lost to this disease. Together, we raise awareness and push forward in the fight against breast cancer. Early detection and continued innovation in treatments make all the difference. Let’s keep working towards a future where breast cancer is a thing of the past. #BreastCancerAwareness #TogetherWeFight #ImmPACTBio

Welcome to the ImmPACT Bio team, Jenny Gong! #welcometotheteam, #CARTcelltherapy, #MakeAnImmPACT

ImmPACT Bio is pleased to announce that we will participate at the 2024 Cell and Gene Meeting on the Mesa, to be held October 7-9, 2024 in Phoenix, AZ. #cartcelltherapy, #CGMesa24, #MakeAnImmPACT